Articles & Resources

Insights

Below is a collection of articles, resources and stories from the Invetech team and industry experts, sharing their knowledge, experiences and advice on product development and market trends.

Filter insights

Additional Insights

Transforming T Cell Manufacturing via Elutriation with Korus™ Webinar Video

Michelle Duquette, Director of Business Development, Cell Therapy discusses how the closed Korus system could streamline and improve your cell and gene therapy manufacturing process from process development to GMP production.

Where to Next in Cell Therapy Manufacturing?

David Hodl, Head of Business Development, Cell Therapy discusses some of the challenges the industry is facing and taking therapy development from the lab to commercial scale.

How New Korus™ Technology is Helping Transform T Cell Manufacturing via Elutriation

Applications Scientist Thikrayat (Tina) Al-Attar, PhD discusses the benefits of utilizing the new Korus™ technology in cell therapy manufacturing and tackling some of the current challenges in the advanced therapies industry.

Diagnostic Device Development in the Era of Cybersecurity Regulations

The interconnectivity of diagnostic technology is revolutionizing healthcare - but also introducing significant risk. Here’s what you need to know about diagnostic device development in the era of cybersecurity regulations.

4 Must-Haves for POC Diagnostic Solutions

What product features are required for success in Point of Care (POC) diagnostics? Two executives from leading POC companies share their 4 “must-haves”.

5 Things to Look Out for in Cell Therapy Supply Chain in 2022

How to navigate global supply chain challenges to help avoid cell therapy manufacturing production bottlenecks this year

How to Successfully Design and Commercialize a Point of Care Platform

In our recent webinar, Kfir Oved from MeMed and Paul Gargan from Prominex shared real-world experiences and insights for succeeding in the Point of Care (POC) diagnostics market.

Key Considerations for Automating Cell Therapy Manufacturing Processes

Invetech’s Jon Ellis and TreeFrog Therapeutics’ Maxime Feyeux discuss cell therapy process automation, development time and costs and automating ancillary processes.

Rethink Cell Therapy QC with Release by Exception

The cell and gene therapy industry could move away from lengthy and costly QC reviews - while still upholding high quality standards - by employing release by exception methods.

Reducing the Manufacturing Costs of Allogeneic Cell Therapies

For allogeneic cell therapies to reach their therapeutic potential, it comes down to achieving scalable and robust manufacturing processes.

3 Strategies for Delivering a Point of Care Platform That Stands Out

To attract investment and get traction in the market, Point of Care diagnostic developers must deliver a platform that is differentiated. Focus on these 3 essential strategies to make it happen.

Establishing a QA/QC Strategy for Point of Care Consumables

Time to market is crucial. Having a well-planned QA/QC strategy will ensure your product launch is not delayed due to consumables production. Follow this 4-step workflow to get started.